DeepMind uses AI agents to find antimicrobial peptide candidates, making failed hypotheses cheaper
krishnan · x · 2026-11-07
Using Google DeepMind's October 15 antimicrobial-peptide walkthrough as an example, the author argues for an underrated way AI could change science: making the discovery of a failed scientific hypothesis cheaper.
- In the DeepMind demo, researchers used an agent to search protein databases, examine predicted structures and genomic context, and prepare a lab test plan.
- The candidate (a proposed antimicrobial lead) was still in wet-lab validation when published — not a demonstrated treatment or clinical proof.
If the route from an overlooked sequence to a runnable experiment gets cheaper, small labs could investigate questions they previously lacked time or specialist support to pursue, making far more hypotheses testable.
More from AGI Musings
- AI-generated peer reviews at ICLR/NeurIPS punish papers for stating their own limitations — serrjoa · 2026-11-07
- You.com CEO Richard Socher: AI's next frontier is science, not code — PolarBearby · 2026-11-07
- Reward hacking all the way through the AI reviewer / AC stack — Michael_D_Moor · 2026-11-07
- 'I really hope LLMs aren't conscious': the AI community's unease keeps growing — AaronBergman18 · 2026-11-07
- Martin Casado slams sloppy use of RSI term as fear-mongering that fuels ban calls — anshulkundaje · 2026-11-07
- WashU Endowment CIO Scott Wilson: SpaceX hit 20% of AUM, half of AI firms may vanish in a decade — 20VC · 2026-11-07